Hillstream BioPharma Inc. (HILS) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 65 transactions totaling $103.7K, demonstrating a bullish sentiment with $103.7K in net insider flow. The most recent transaction on Jul 14, 2022 involved a transaction of 75,757 shares valued at $0.
No significant insider buying has been recorded for HILS in the recent period.
No significant insider selling has been recorded for HILS in the recent period.
Based on recent SEC filings, insider sentiment for HILS is bullish with an Insider Alignment Score of 100/100 and a net flow of $103.7K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Hillstream BioPharma Inc. (HILS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading HILS stock, having executed 65 transactions in the past 90 days. The most active insider is Randy Milby (Executive), who has made 61 transactions totaling $3.0M.
Get notified when executives and directors at HILS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 14, 2022 | Appajosyula Sireesh | Executive | Gift | 75,757 | $N/A | $0 | |
| Jul 14, 2022 | Appajosyula Sireesh | Executive | Gift | 7,576 | $N/A | $0 | |
| Jun 17, 2022 | Milby Randy | Executive | Purchase | 500 | $0.78 | $390 | |
| Jun 6, 2022 | Milby Randy | Executive | Purchase | 500 | $0.70 | $350 | |
| Jun 6, 2022 | Milby Randy | Executive | Purchase | 66 | $0.67 | $44 | |
| Jun 6, 2022 | Milby Randy | Executive | Purchase | 100 | $0.67 | $67 | |
| Jun 6, 2022 | Milby Randy | Executive | Purchase | 100 | $0.67 | $67 | |
| Jun 6, 2022 | Milby Randy | Executive | Purchase | 234 | $0.68 | $159 | |
| Jun 1, 2022 | Milby Randy | Executive | Purchase | 1 | $0.94 | $1 | |
| May 25, 2022 | Milby Randy | Executive | Purchase | 800 | $0.79 | $632 | |
| May 25, 2022 | Milby Randy | Executive | Purchase | 200 | $0.77 | $154 | |
| May 20, 2022 | Milby Randy | Executive | Purchase | 500 | $0.89 | $445 | |
| May 20, 2022 | Milby Randy | Executive | Purchase | 500 | $0.95 | $475 | |
| May 19, 2022 | Milby Randy | Executive | Purchase | 500 | $0.90 | $450 | |
| May 19, 2022 | Milby Randy | Executive | Purchase | 500 | $0.92 | $460 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 44 | $3.3M | 96.2% |
Purchase(P) | 14 | $103.7K | 3.1% |
Exercise (Options)(X) | 5 | $24.5K | 0.7% |
Gift(G) | 2 | $0 | 0.0% |
Insiders at Hillstream BioPharma Inc. are accumulating shares at an accelerated pace. With 3 insiders making 65 transactions totaling $103.7K in purchases versus $0 in sales, the net buying activity of $103.7K signals strong executive confidence. Randy Milby (Executive) leads the buying activity with $3.0M in transactions across all time.